XML 22 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Equity Method Investments and Related Party Transactions (Tables)
 12 Months Ended
Dec. 31, 2014
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Contributions to Equity Method Investment
The following table summarizes Redbox's initial cash capital contribution and subsequent cash capital contributions representing its pro-rata share of requests made by the Joint Venture board of managers:
Dollars in thousands
Cash Contributions
2012
$
24,500

2013
28,000

2014
24,500

Total cash capital contributions
$
77,000
Schedule of Equity Method Investments
Income (loss) from equity method investments within our Consolidated Statements of Comprehensive Income is composed of the following:
 
Year Ended December 31,
Dollars in thousands
2014
 
2013
 
2012
Trademark gain
$
—

 
$
—

 
$
19,500

Gain on previously held equity interest in ecoATM
—

 
68,376

 
—

Proportionate share of net loss of equity method investees:
 
 
 
 

Joint Venture
(25,793
)
 
(42,660
)
 
(20,236
)
ecoATM and SoloHealth
(530
)
 
(3,313
)
 
(2,179
)
Total proportionate share of net loss of equity method investees
(26,323
)
 
(45,973
)
 
(22,415
)
Amortization of difference in carrying amount and underlying equity in Joint Venture
(2,411
)
 
(2,475
)
 
(2,269
)
Total income (loss) from equity method investments
$
(28,734
)
 
$
19,928

 
$
(5,184
)


A summary of financial information for our equity method investees in the aggregate, as provided to us by the investees, is as follows and includes the balance sheet as of and statement of operations through October 20, 2014, the date of our withdrawal from the Joint Venture, and as of December 31, 2014 and the period ended December 31, 2014 for SoloHealth:
Balance Sheets
 
October 20,
 
December 31,
Dollars in thousands
 
2014(1)
 
2014(2)
 
2013
Current assets
 
$
9,095

 
$
3,408

 
$
32,832

Noncurrent assets
 
$
3,053

 
$
20,376

 
$
30,765

Current liabilities
 
$
86,735

 
$
7,321

 
$
46,706

Long-term liabilities
 
$
—

 
$
18,754

 
$
23,905

Redeemable preferred stock
 
$
—

 
$
23,734

 
$
23,542

(1) Represents the Joint Venture only
(2) Represents SoloHealth only
Statement of Operations
Year Ended December 31,
Dollars in thousands
2014
 
2013
 
2012
Revenue
$
29,963

 
$
15,824

 
$
2,067

Cost of sales and service
$
68,732

 
$
25,092

 
$
10,716

Net loss and loss from continuing operations
$
140,919

 
$
134,911

 
$
58,510